To evaluate the anti-tumor effect of CD55-Smad4 in vitro, four CRC cell lines HCT116, HT-29, SW620, and SW480, were infected with various concentrations of CD55-Smad4 for 48 h. This evidence concerns the gene SMAD4 and colorectal carcinoma.